沃爾核材(002130.SZ):沃爾新科技擬以不超1200萬元參與競拍土地使用權
格隆匯3月4日丨沃爾核材(002130.SZ)公佈,公司於2024年3月4日召開了第七屆董事會第十三次會議,以9票同意、0票反對、0票棄權審議通過了《關於控股子公司擬參與競拍土地使用權的議案》,為滿足公司控股子公司對經營場地的需求,同意公司控股子公司惠州市沃爾新科技有限公司(簡稱“沃爾新科技”)以不超過人民幣1200萬元的自籌資金參與競拍土地使用權,本次擬競拍的土地為位於惠州市惠城區水口民營工業園南區JD-130-10地塊土地面積為9,085平方米的工業用地。本次土地競買起始價為人民幣950萬元,競買保證金為人民幣285萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.